PER
Click for more information
7.50% 8.6¢ percheron therapeutics limited

One Study Away, page-5

  1. Uboy
    4,710 Posts.
    lightbulb Created with Sketch. 1097
    clock Created with Sketch.
    19/11/20
    13:15
    Post #: 48989396
    Yes, because it may impact potential partners getting involved in P2B combination therapy trial.

    ODD in EU gives 10 years market exclusivity amongst other advantages. It is definitely another de-risking event for ANP.

    There have also been hints by CEO around one big P2B concurrent trial in US and EU - with results being used to appease both FDA and EMA.
    Last edited by Uboy: 19/11/20
    ANP Price at posting: 11.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Trump is President Again: What Does This Mean for Crypto?
right-arrow Created with Sketch.
NEWS Imugene kicks off Australian trial for blood cancer treatment
right-arrow Created with Sketch.
EQN Equinox Resources reports outstanding naturally occurring antimony grade at Alturas Project
right-arrow Created with Sketch.
3DA To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels
right-arrow Created with Sketch.
NEWS Update on the ASX' most anticipated drill campaign
right-arrow Created with Sketch.
NEWS HotCopper Highlights: Your most watched and most discussed stocks this week
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.6¢ 		Change
0.006(7.50%) 		Mkt cap ! $89.16M
Open High Low Value Volume
8.3¢ 8.9¢ 8.1¢ $294.9K 3.491M

Buyers (Bids)

No. Vol. Price($)
1 49999 8.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 16887 1
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.